Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent

• Auteurs principaux: Paola Patrignani (Auteur), Emanuela Ricciotti (Auteur), Stefania Tacconelli (Auteur), Carlos Sostres (Auteur), Melania Dovizio (Auteur)
• Format: Livre
• Publié: MDPI AG, 2012-12-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Recent findings have shown that aspirin, taken for several years, reduces the long-term risk of some cancers, particularly colorectal cancer. The result that aspirin benefit is detectable at daily low-doses (at least 75mg), the same used for the prevention of cardiovascular disease, positions the an...